SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-19-000006
Filing Date
2019-02-01
Accepted
2019-02-01 08:21:54
Documents
5
Period of Report
2019-02-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctic-form8xkfebruary2019pr.htm 8-K 32541
2 EXHIBIT 99.1 cticprpacritinibchmpwith.htm EX-99.1 7484
3 cticprpacritinibchmpwith001.jpg GRAPHIC 167786
4 cticprpacritinibchmpwith002.jpg GRAPHIC 202920
5 cticprpacritinibchmpwith003.jpg GRAPHIC 35624
  Complete submission text file 0000891293-19-000006.txt   601266
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 19557778
SIC: 2834 Pharmaceutical Preparations